Optimization of Novel Aza-Benzimidazolone mGluR2 PAMs With Respect to LLE and PK Properties and Mitigation of CYP TDI

doi 10.1021/acsmedchemlett.5b00459.s001
Full Text
Abstract

Available in full text

Date

Unknown

Authors

Unknown

Publisher

American Chemical Society (ACS)


Related search